DISCLOSEABLE TRANSACTION - PURCHASE OF WEALTH MANAGEMENT PRODUCTS

ARTICLES OF ASSOCIATION

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

(1) POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING; (2) ELECTION OF DIRECTORS FOR THE THIRD SESSION OF THE BOARD; (3) ELECTION OF THE EMPLOYEE REPRESENTATIVE DIRECTOR; AND (4) THE CHAIRMAN OF THE BOARD, THE CHIEF EXECUTIVE OFFICER OF THE COMPANY AND THE COMPOSITION OF THE BOARD COMMITTEES

VOLUNTARY ANNOUNCEMENT - NMPA CONDITIONALLY APPROVES MARKETING FOR THE NEW INDICATION OF TELITACICEPT INJECTION (RC18) FOR THE TREATMENT OF IGA NEPHROPATHY

VOLUNTARY ANNOUNCEMENT - NMPA APPROVES MARKETING FOR THE NEW INDICATION OF TELITACICEPT FOR INJECTION (RC18) FOR THE TREATMENT OF SJOGREN'S SYNDROME(SJOGREN'S DISEASE)

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026

(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026

DISCLOSEABLE TRANSACTION - PURCHASE OF WEALTH MANAGEMENT PRODUCT

DISCLOSEABLE TRANSACTION - PURCHASE OF WEALTH MANAGEMENT PRODUCT